VMP 42041511000001106

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Rivastigmine 3mg capsules
BNF code 0411000E0AAABAB
Virtual Therapeutic Moiety Rivastigmine
Date identifier became valid 7 Jul 2023
Previous product identifier 323370000
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units capsule
Unit dose unit of measure capsule
Virtual Product Ingredient
Ingredient Rivastigmine hydrogen tartrate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 395868008
Strength value numerator 3.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route capsule.oral
Dose Form
Formulation Oral capsule
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Rivastigmine 3mg capsules (A A H Pharmaceuticals Ltd)
Rivastigmine 3mg capsules (Alliance Healthcare (Distribution) Ltd)
Rivastigmine 3mg capsules (Bristol Laboratories Ltd)
Rivastigmine 3mg capsules (Crescent Pharma Ltd)
Rivastigmine 3mg capsules (Dr Reddy's Laboratories (UK) Ltd)
Rivastigmine 3mg capsules (Krka UK Ltd)
Rivastigmine 3mg capsules (Medihealth (Northern) Ltd)
Rivastigmine 3mg capsules (Sandoz Ltd)
Rivastigmine 3mg capsules (Torrent Pharma (UK) Ltd)
Rivastigmine 3mg capsules (Viatris UK Healthcare Ltd)
Virtual Medicinal Product Packs
Rivastigmine 3mg capsules 28 capsule
Rivastigmine 3mg capsules 56 capsule

dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.

Feedback